Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2296 AL 2310

Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the disease

Bendetowicz D, Planche V, Bezard E, Dehay B, Meissner WG.

J Parkinsons Dis. 2025 Aug;15(5):944-952. doi: 10.1177/1877718X241313443. Epub 2025 Feb 4.

Aging, cellular senescence and Parkinson's disease

Ma Y, Erb ML, Moore DJ.

J Parkinsons Dis. 2025 Mar;15(2):239-254. doi: 10.1177/1877718X251316552. Epub 2025 Feb 2.

Lactobacillaceae and Parkinson's disease: An apparent paradox

van der Maden MM, Verbeek MM, Beckers M.

J Parkinsons Dis. 2025 Mar;15(2):269-281. doi: 10.1177/1877718X241312401. Epub 2025 Jan 29.

From blood vessels to brain cells: Connecting the circulatory system and Parkinson's disease

Olaoye OJ, Farrow SL, Nyaga DM, Cooper AA, O'Sullivan JM.

J Parkinsons Dis. 2025 Mar;15(2):255-268. doi: 10.1177/1877718X241308168. Epub 2025 Jan 29.

Technology for measuring freezing of gait: Current state of the art and recommendations

Mancini M, McKay JL, Cockx H, D'Cruz N, Esper CD, Filtjens B, Heimler B, MacKinnon CD, Palmerini L, Roerdink M, Young WR, Hausdorff JM; ICFOG Investigators.

J Parkinsons Dis. 2025 Feb;15(1):19-40. doi: 10.1177/1877718X241301065. Epub 2025 Jan 14.

SynNeurGe: The road ahead for a biological definition of Parkinson's disease

Höglinger GU, Lang AE.

J Parkinsons Dis. 2025 Aug;15(5):931-938. doi: 10.1177/1877718X241298194. Epub 2024 Dec 8.

Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report

Fleury V, Tomkova E, Catalano Chiuvé S, Penzenstadler L.

J Parkinsons Dis. 2025 Mar;15(2):440-444. doi: 10.1177/1877718X241312604. Epub 2025 Feb 2.

Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial

Ferreira JJ, Gago MF, Costa R, Fonseca MM, Almeida J, Rocha JF, Holenz J, Trenkwalder C.

J Parkinsons Dis. 2025 Feb;15(1):87-96. doi: 10.1177/1877718X241306711. Epub 2025 Jan 17.

A possible pathway to freezing of gait in Parkinson's disease

Factor SA, Weinshenker D, McKay JL.

J Parkinsons Dis. 2025 Mar;15(2):282-290. doi: 10.1177/1877718X241308487. Epub 2025 Jan 14.

Proposed biological definitions of Parkinson's disease confuse understanding without delivering meaningful advances

Cardoso F, Schmidt P.

J Parkinsons Dis. 2025 Aug;15(5):939-943. doi: 10.1177/1877718X241308482. Epub 2025 Jan 14.

Rethinking 'rare' PINK1 Parkinson's disease: A meta-analysis of geographical prevalence, phenotypic diversity, and α-synuclein pathology

Yin EP, Dieriks BV.

J Parkinsons Dis. 2025 Feb;15(1):41-65. doi: 10.1177/1877718X241304814. Epub 2025 Jan 14.

Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's disease

Griffith GJ, Mehta N, Lamotte G, McKee KE, Suttman E, Haus JM, Joslin E, Balfany K, Kohrt WM, Christiansen CL, Melanson EL, Chahine LM, Christou DD, Patterson CG, Corcos DM.

J Parkinsons Dis. 2025 Mar;15(2):387-396. doi: 10.1177/1877718X241308813. Epub 2025 Jan 14.

Improving reliability of movement assessment in Parkinson's disease using computer vision-based automated severity estimation

Xu J, Xu X, Guo X, Li Z, Dong B, Qi C, Yang C, Zhou D, Wang J, Song L, He P, Kong S, Zheng S, Fu S, Xie W, Liu X, Cao Y, Liu Y, Qiu Y, Zheng Z, Yang F, Gan J, Wu X.

J Parkinsons Dis. 2025 Mar;15(2):349-360. doi: 10.1177/1877718X241312605. Epub 2025 Feb 13.

Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study

Isaacson SH, Espay AJ, Pahwa R, Agarwal P, Shill HA, Hui J, Dashtipour K, Lew M, Qin P, Formella AE, Ceresoli-Borroni G, LeWitt PA; InfusON Study Group.

J Parkinsons Dis. 2025 Mar;15(2):361-373. doi: 10.1177/1877718X241310727. Epub 2025 Jan 29.

Machine learning prediction algorithms for 2- , 5- and 10-year risk of Alzheimer's, Parkinson's and dementia at age 65: a study using medical records from France and the UK General Practitioners

Nedelec T, Zaidi K, Montaud C, Guinebretiere O, Sipilä P, Wei D, Yang F, Freydenzon A, Belloir A, Fournier N, Hamieh N, Lekens B, Slaouti Y, McRae A, Couvy-Duchesne B, Hswen Y, Fang F, Kivimäki M, Ansart M, Durrleman S.

medRxiv [Preprint]. 2025 Jan 25:2025.01.22.25320969. doi: 10.1101/2025.01.22.25320969.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias